Popovits Kimberly J
SEC insider (Form 3/4/5 filer). CIK 0001333482. Director at Kardigan, Inc. (KARD) and 4 other issuers. 18 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in LONDON.
Companies Popovits Kimberly J has filed insider reports for
- Kardigan, Inc. (KARD): Director
- 10x Genomics, Inc. (TXG): Director
- Kiniksa Pharmaceuticals International, plc (KNSA): Director
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Director
- EXACT SCIENCES CORP (EXAS): Director
Popovits Kimberly J
CIK: 0001333482
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 17, 2026KARD
Kardigan, Inc.
AwardDirect20.7K shares- - Jun 4, 2026TXG
10x Genomics, Inc.
AwardDirect8.8K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Units
2K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.8K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
12.2K shares- - Apr 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectStock Options (Right to Buy)
10.3K shares- - Apr 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
6.8K shares- - Mar 23, 2026EXAS
EXACT SCIENCES CORP
DispositionDirect9.7K shares- - Mar 23, 2026EXAS
EXACT SCIENCES CORP
DispositionDirect6.7K shares- - Jul 30, 2025KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect45.7K shares at avg. $10.36$474K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  KARD Kardigan, Inc. | Award | 20,706 | - | $0 | Direct |
| Jun 4, 2026 |  TXG 10x Genomics, Inc. | Award | 8,829 | - | $0 | Direct |
| May 29, 2026 |  KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Units | 2,026 | - | - | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,799 | - | $0 | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 12,158 | - | - | Direct |
| Apr 1, 2026 |  RYTM RHYTHM PHARMACEUTICALS, INC. | Award Stock Options (Right to Buy) | 10,257 | - | - | Direct |
| Apr 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Restricted Stock Units | 6,808 | - | - | Direct |
| Mar 23, 2026 |  EXAS EXACT SCIENCES CORP | Disposition | 9,656 | - | $0 | Direct |
| Mar 23, 2026 | EXAS EXACT SCIENCES CORP | Disposition | 6,725 | - | $0 | Direct |
| Jul 30, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 45,748 | $10.36 | $473,949 | Direct |
1-10 of 18 transactions